![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Treatment-naïve, genotype-1 HCV-infected subjects show significantly greater HCV RNA decreases when treated with 28 days of ABT-333 plus peginterferon and ribavirin compared to peginterferon and ribavirin alone
|
|
|
Reported by Jules Levin
AASLD Nov 2 2009, Boston, MA
Maribel Rodriguez-Torres1, Eric Lawitz2, Daniel E. Cohen3,
Lois Larsen3, Rajeev M. Menon3, Christine Collins3,
Theresa Marsh3, Sara Gibbs3, and Barry Bernstein3
1. Fundacion de Investigacion de Diego, San Juan, Puerto Rico; 2. Alamo Medical Research, San Antonio, TX; 3. Abbott, Abbott Park, IL
![image002.gif](../images/110609/110609-4/image002.gif)
![image004.gif](../images/110609/110609-4/image004.gif)
![image006.gif](../images/110609/110609-4/image006.gif)
![image008.gif](../images/110609/110609-4/image008.gif)
![image010.gif](../images/110609/110609-4/image010.gif)
![image012.gif](../images/110609/110609-4/image012.gif)
![image014.gif](../images/110609/110609-4/image014.gif)
![image016.gif](../images/110609/110609-4/image016.gif)
![image018.gif](../images/110609/110609-4/image018.gif)
![image020.gif](../images/110609/110609-4/image020.gif)
![image022.gif](../images/110609/110609-4/image022.gif)
![image024.gif](../images/110609/110609-4/image024.gif)
![image026.gif](../images/110609/110609-4/image026.gif)
![image028.gif](../images/110609/110609-4/image028.gif)
![image030.gif](../images/110609/110609-4/image030.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|